Skip to content
10-Q

Quarterly Report

Outset Medical, Inc. OM

0001193125-26-212481

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 18.54M sh
Shares Diluted Q1 2026 · Mar 31, 2026 18.37K sh
Shares Diluted Q1 2026 · Mar 31, 2025 7.04K sh
Capex Q1 2026 · Mar 31, 2026 $65K
Capex Q1 2026 · Mar 31, 2025 $123K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$12.84M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$25.66M
Long Term Debt Q1 2026 · Mar 31, 2026 $96.94M
Long Term Debt Q1 2026 · Dec 31, 2025 $96.24M
Short Term Investments Q1 2026 · Mar 31, 2026 $126.14M
Short Term Investments Q1 2026 · Dec 31, 2025 $133.94M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $30.56M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $35.01M
Stockholders Equity Q1 2026 · Mar 31, 2026 $111.69M
Stockholders Equity Q1 2026 · Dec 31, 2025 $126.95M
Stockholders Equity Q1 2026 · Mar 31, 2025 $169.87M
Stockholders Equity Q1 2026 · Dec 31, 2024 $26.82M
Current Liabilities Q1 2026 · Mar 31, 2026 $37.61M
Current Liabilities Q1 2026 · Dec 31, 2025 $37.63M
Total Liabilities Q1 2026 · Mar 31, 2026 $137.77M
Total Liabilities Q1 2026 · Dec 31, 2025 $137.54M
Current Assets Q1 2026 · Mar 31, 2026 $236.71M
Current Assets Q1 2026 · Dec 31, 2025 $250.88M
Total Assets Q1 2026 · Mar 31, 2026 $249.45M
Total Assets Q1 2026 · Dec 31, 2025 $264.5M
Eps Diluted Q1 2026 · Mar 31, 2026 −$1.03
Eps Diluted Q1 2026 · Mar 31, 2025 −$3.66
Eps Basic Q1 2026 · Mar 31, 2026 −$1.03
Eps Basic Q1 2026 · Mar 31, 2025 −$3.66
Sga Expense Q1 2026 · Mar 31, 2026 $10.12M
Sga Expense Q1 2026 · Mar 31, 2025 $8.3M
Rd Expense Q1 2026 · Mar 31, 2026 $5.62M
Rd Expense Q1 2026 · Mar 31, 2025 $5.52M
Net Income Q1 2026 · Mar 31, 2026 −$18.98M
Net Income Q1 2026 · Mar 31, 2025 −$25.78M
Operating Income Q1 2026 · Mar 31, 2026 −$16.92M
Operating Income Q1 2026 · Mar 31, 2025 −$16.4M
Gross Profit Q1 2026 · Mar 31, 2026 $12.1M
Gross Profit Q1 2026 · Mar 31, 2025 $11.07M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $15.77M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $18.69M
Revenue Q1 2026 · Mar 31, 2026 $27.86M
Revenue Q1 2026 · Mar 31, 2025 $29.75M